A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 30
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LBVS
Long Form : ligand-based virtual screening
No. Year Title Co-occurring Abbreviation
2020 Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach. MAO-B, MVD, PD, SB
2020 Identification of Novel TRPC5 Inhibitors by Pharmacophore-Based and Structure-Based Approaches. CKD, SBVS, TRP, TRPC5
2020 Improved Scaffold Hopping in Ligand-Based Virtual Screening Using Neural Representation Learning. ---
2020 Insights into Machine Learning-based approaches for Virtual Screening in Drug Discovery: Existing strategies and streamlining through FP-CADD. FP-CADD, RF, SBVS, SVM
2019 A bioinspired in vitro bioelectronic tongue with human T2R38 receptor for high-specificity detection of N-C=S-containing compounds. BioET, ECIS, PROP, PTC
2019 Applying Machine Learning to Ultrafast Shape Recognition in Ligand-Based Virtual Screening. ANNs, GMMs, LECs, USR
2019 ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects. ASK1, SBVS
2019 Ligand based screening of chemical constituents from African medicinal plants for the identification of MAOB inhibitors. PEA, RF
2019 Ligand based screening of chemical constituents from African medicinal plants for the identification of MAOB inhibitors. PEA, RF
10  2018 Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors. SBVS
11  2017 Quantum probability ranking principle for ligand-based virtual screening. MDDR, PRP, PRP, QPRP
12  2017 The identification of new ATAD2 bromodomain inhibitors: the application of combined ligand and structure-based virtual screening. SBVS
13  2016 Comparative Analysis of QSAR-based vs. Chemical Similarity Based Predictors of GPCRs Binding Affinity. GPCRs, k-NN, PASS, QSAR, SEA
14  2015 Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors. GPCRs, H1R, H4R, LGIC
15  2015 Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families. HDACIs, HDACs, MUBD-HDACs, VS
16  2015 Optimization of TRPV6 Calcium Channel Inhibitors Using a 3D Ligand-Based Virtual Screening Method. ---
17  2015 Stereoselective virtual screening of the ZINC database using atom pair 3D-fingerprints. APfp, APfp
18  2015 Three-dimensional compound comparison methods and their application in drug discovery. ---
19  2014 An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs. CV, GDD, GLL, GPCRs, LOO, SBVS, UDS, ULS
20  2014 Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening. GPCRs, PLIF, SBVS
21  2014 LBVS: an online platform for ligand-based virtual screening using publicly accessible databases. ---
22  2013 Visualization and virtual screening of the chemical universe database GDB-17. MQN
23  2012 Ligand expansion in ligand-based virtual screening using relevance feedback. ---
24  2011 G-protein coupled receptors virtual screening using genetic algorithm focused chemical space. GA, GAFDAS, GPCRs
25  2011 Integration of Ligand- and Target-Based Virtual Screening for the Discovery of Cruzain Inhibitors. HQSAR, ROC, TBVS
26  2011 Rationalizing the role of SAR tolerance for ligand-based virtual screening. SAR
27  2011 Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models. QSAR
28  2009 Exploring novel target space: a need to partner high throughput docking and ligand-based similarity searches? CADD, CC, HTD, HTS, SBVS
29  2009 Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening. GRIND
30  2004 POT-DMC: A virtual screening method for the identification of potent hits. DMC, POT-DMC